Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-02
DOI
10.1038/s41598-018-25588-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
- (2017) Maryam Moradi Binabaj et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Gas Chromatography/Mass Spectrometry Metabolomics of Urine and Serum from Nonhuman Primates Exposed to Ionizing Radiation: Impacts on the Tricarboxylic Acid Cycle and Protein Metabolism
- (2017) Evan L. Pannkuk et al. JOURNAL OF PROTEOME RESEARCH
- Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization
- (2017) Delphine Garnier et al. NEURO-ONCOLOGY
- Safety and Effectiveness of Bis-Chloroethylnitrosourea Wafer Chemotherapy in Elderly Patients with Recurrent Glioblastoma
- (2017) Johann Klein et al. ONCOLOGY
- A systematic genomic screen implicates nucleocytoplasmic transport and membrane growth in nuclear size control
- (2017) Kazunori Kume et al. PLoS Genetics
- Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment
- (2016) Adrian Schimanski et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair
- (2016) Markus Christmann et al. Oncotarget
- Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling
- (2016) Antonina Frolov et al. Scientific Reports
- Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement
- (2015) Xue Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SDHBmutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
- (2014) Julien Hadoux et al. INTERNATIONAL JOURNAL OF CANCER
- RRAD Promotes EGFR-Mediated STAT3 Activation and Induces Temozolomide Resistance of Malignant Glioblastoma
- (2014) S.-Y. Yeom et al. MOLECULAR CANCER THERAPEUTICS
- Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma
- (2014) Frederic Mack et al. ONCOLOGY
- The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis
- (2014) An-an Yin et al. PLoS One
- STAT5A/B Gene Locus Undergoes Amplification during Human Prostate Cancer Progression
- (2013) Bassem R. Haddad et al. AMERICAN JOURNAL OF PATHOLOGY
- MetaboLyzer: A Novel Statistical Workflow for Analyzing Postprocessed LC–MS Metabolomics Data
- (2013) Tytus D. Mak et al. ANALYTICAL CHEMISTRY
- Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme: A Systematic Review
- (2013) Li-Juan Yang et al. CANCER INVESTIGATION
- Cell migration or cytokinesis and proliferation? – Revisiting the “go or grow” hypothesis in cancer cells in vitro
- (2013) Tamás Garay et al. EXPERIMENTAL CELL RESEARCH
- The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis
- (2013) Kui Zhang et al. Familial Cancer
- GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients
- (2013) Satoshi Nakamizo et al. JOURNAL OF NEURO-ONCOLOGY
- Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma
- (2012) Pasquale De Bonis et al. ACTA NEUROCHIRURGICA
- The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models
- (2012) S V Holt et al. BRITISH JOURNAL OF CANCER
- A SDHB malignant paraganglioma with dramatic response to temozolomide–capecitabine
- (2012) Cécile Nozières et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells
- (2012) Caroline Happold et al. JOURNAL OF NEUROCHEMISTRY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis
- (2011) Atsushi Sato et al. STEM CELLS
- Treatment results, including clinical prognostic factors and MGMT gene promoter methylation, in patients with glioblastoma multiforme in Warmia and Mazury Oncology Centre
- (2011) Beata Czeremszyńska et al. Wspolczesna Onkologia-Contemporary Oncology
- BoneJ: Free and extensible bone image analysis in ImageJ
- (2010) Michael Doube et al. BONE
- Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain
- (2010) Claudia R. Oliva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 'Go or Grow': the key to the emergence of invasion in tumour progression?
- (2010) H. Hatzikirou et al. MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA
- Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells
- (2008) Roberto Papait et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of transcription factor STAT5b suppresses proliferation, induces G1 cell cycle arrest and reduces tumor cell invasion in human glioblastoma multiforme cells
- (2008) Qin-Chuan Liang et al. CANCER LETTERS
- Carmustine-Resistant Cancer Cells Are Sensitized to Temozolomide As A Result of Enhanced Mismatch Repair during the Development of Carmustine Resistance
- (2008) T. Yamauchi et al. MOLECULAR PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started